PT1787658E - Formulações de libertação sustentada de análogos de somatostatina inibidores da hormona do crescimento - Google Patents
Formulações de libertação sustentada de análogos de somatostatina inibidores da hormona do crescimento Download PDFInfo
- Publication number
- PT1787658E PT1787658E PT05077559T PT05077559T PT1787658E PT 1787658 E PT1787658 E PT 1787658E PT 05077559 T PT05077559 T PT 05077559T PT 05077559 T PT05077559 T PT 05077559T PT 1787658 E PT1787658 E PT 1787658E
- Authority
- PT
- Portugal
- Prior art keywords
- pharmaceutical formulation
- formulation according
- growth hormone
- somatostatin analogue
- hormone releasing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/31—Somatostatins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Endocrinology (AREA)
- Dermatology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP05077559A EP1787658B1 (en) | 2005-11-10 | 2005-11-10 | Sustained release formulations of somatostatin analogue inhibitors of growth hormone |
Publications (1)
Publication Number | Publication Date |
---|---|
PT1787658E true PT1787658E (pt) | 2012-06-22 |
Family
ID=35840709
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT05077559T PT1787658E (pt) | 2005-11-10 | 2005-11-10 | Formulações de libertação sustentada de análogos de somatostatina inibidores da hormona do crescimento |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP1787658B1 (pl) |
AT (1) | ATE549011T1 (pl) |
CY (1) | CY1112857T1 (pl) |
DK (1) | DK1787658T3 (pl) |
ES (1) | ES2383303T3 (pl) |
PL (1) | PL1787658T3 (pl) |
PT (1) | PT1787658E (pl) |
SI (1) | SI1787658T1 (pl) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0602639D0 (en) * | 2006-02-09 | 2006-03-22 | Novartis Ag | Organic compounds |
JP5331817B2 (ja) * | 2007-12-03 | 2013-10-30 | イタルファルマコ ソシエタ ペル アチオニ | 新規な非選択的ソマトスタチン類似体 |
ITUB20160416A1 (it) * | 2016-01-28 | 2017-07-28 | Italfarmaco Spa | Uso di una formulazione a lento rilascio di octreotide per la prevenzione della formazione di seroma |
Family Cites Families (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3045135A1 (de) | 1980-11-29 | 1982-06-09 | Sandoz-Patent-GmbH, 7850 Lörrach | Pharmazeutische kompositionen enthaltende bioabbaubare polymere |
FR2537980B1 (fr) | 1982-12-17 | 1986-12-19 | Sandoz Sa | Derives d'acides hydroxycarboxyliques oligomeres, leur preparation et leur utilisation |
GB8318552D0 (en) | 1983-07-08 | 1983-08-10 | Sandoz Ltd | Organic compounds |
HU198626B (en) | 1986-05-27 | 1989-11-28 | Sandoz Ag | Process for producing pharmaceutical compositions comprising somatostatin analogues as active ingredient |
GB2193891B (en) | 1986-08-18 | 1990-07-25 | Sandoz Ltd | Nasal pharmaceutical composition containing a somatostatin anologue. |
HU906341D0 (en) | 1986-10-13 | 1991-04-29 | Sandoz Ag | Process for producing peptonic derivatives modified with sugar and pharmaceutical preparatives containing these compounds as active substance |
DE3822557C2 (de) | 1987-07-10 | 1998-07-02 | Ciba Geigy Ag | Arzneimittel, enthaltend Somatostatine |
US5538739A (en) | 1989-07-07 | 1996-07-23 | Sandoz Ltd. | Sustained release formulations of water soluble peptides |
MY108621A (en) | 1990-08-01 | 1996-10-31 | Novartis Ag | Polylactide preparation and purification |
GB9206736D0 (en) | 1992-03-27 | 1992-05-13 | Sandoz Ltd | Improvements of organic compounds and their use in pharmaceutical compositions |
SI9300468A (en) | 1992-10-14 | 1994-06-30 | Hoffmann La Roche | Injectable composition for the sustained release of biologically active compounds |
EP0671937A4 (en) | 1992-10-16 | 1996-09-18 | Smithkline Beecham Corp | COMPOSITIONS FOR PHARMACEUTICAL EMULSIONS. |
WO1995000126A1 (en) | 1993-06-22 | 1995-01-05 | Sandoz Ltd. | Surface-modified albumin microspheres and pharmaceutical compositions containing them |
IL110787A0 (en) | 1993-08-27 | 1994-11-11 | Sandoz Ag | Biodegradable polymer, its preparation and pharmaceutical composition containing it |
EP0896544B1 (en) | 1996-06-11 | 2003-02-26 | Novartis AG | Combination of a somatostatin analogue and a rapamycin |
CA2219698C (en) | 1996-10-31 | 2007-09-04 | Takeda Chemical Industries, Ltd. | Sustained-release preparation |
WO1999021533A2 (en) * | 1997-10-24 | 1999-05-06 | Neorx Corporation | Delivery vehicles for bioactive agents and uses thereof |
GB2331924A (en) | 1997-12-08 | 1999-06-09 | Phares Pharm Res Nv | Lipid compositions and their use |
ES2216447T3 (es) * | 1998-08-17 | 2004-10-16 | Pfizer Products Inc. | Composiciones proteicas estabilizadas. |
US6159935A (en) | 1999-11-29 | 2000-12-12 | Pharmacia & Upjohn Co. | Method for preventing diarrhea |
IT1318539B1 (it) | 2000-05-26 | 2003-08-27 | Italfarmaco Spa | Composizioni farmaceutiche a rilascio prolungato per lasomministrazione parenterale di sostanze idrofile biologicamente |
AU2001283957A1 (en) | 2000-07-27 | 2002-02-13 | Novartis Ag | Treatment of ocular disorders with somatostatin analogues |
US20030049320A1 (en) * | 2000-12-18 | 2003-03-13 | Wockhardt Limited | Novel in-situ forming controlled release microcarrier delivery system |
US20050163853A1 (en) | 2002-04-19 | 2005-07-28 | Lajos Szente | Novel biomaterials their preparation and use |
US20040097419A1 (en) | 2002-11-19 | 2004-05-20 | Holger Petersen | Organic compounds |
GB0228571D0 (en) | 2002-12-06 | 2003-01-15 | Novartis Ag | Organic compounds |
-
2005
- 2005-11-10 EP EP05077559A patent/EP1787658B1/en active Active
- 2005-11-10 AT AT05077559T patent/ATE549011T1/de active
- 2005-11-10 PL PL05077559T patent/PL1787658T3/pl unknown
- 2005-11-10 PT PT05077559T patent/PT1787658E/pt unknown
- 2005-11-10 DK DK05077559.2T patent/DK1787658T3/da active
- 2005-11-10 SI SI200531534T patent/SI1787658T1/sl unknown
- 2005-11-10 ES ES05077559T patent/ES2383303T3/es active Active
-
2012
- 2012-06-11 CY CY20121100528T patent/CY1112857T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
ES2383303T3 (es) | 2012-06-20 |
DK1787658T3 (da) | 2012-06-25 |
EP1787658B1 (en) | 2012-03-14 |
CY1112857T1 (el) | 2016-04-13 |
PL1787658T3 (pl) | 2012-08-31 |
SI1787658T1 (sl) | 2012-07-31 |
ATE549011T1 (de) | 2012-03-15 |
EP1787658A1 (en) | 2007-05-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4954423B2 (ja) | 生物学的に活性な親水性化合物を非経口的に投与するための徐放性薬剤組成物 | |
JP2613750B2 (ja) | 注射可能なレシチンのゲル | |
CA2609810C (en) | Glp-1 analogue formulations | |
ES2458992T3 (es) | Formulaciones de análogos de GnRH | |
CN1273187C (zh) | 稳定性提高的无锌或低锌胰岛素制剂 | |
FI94024B (fi) | Menetelmä nasaalivalmisteiden valmistamiseksi | |
KR100767097B1 (ko) | 안정한 국부적인 약물 전달 조성물 | |
CA2939686C (en) | Peptide slow-release formulations | |
DK2194969T3 (en) | ACID LIPID FORMULATIONS | |
ES2566765T3 (es) | Una composición farmacéutica que contiene 3-beta-hidroxi-5-alfa-pregnan-20-ona con propiedades de almacenamiento y solubilidad mejoradas | |
PT2157967E (pt) | Formulações de suspensões de péptidos insulinotrópicos e suas utilizações | |
NL8203944A (nl) | Gestabiliseerde insulinesamenstellingen en een werkwijze ter bereiding ervan. | |
PL90318B1 (pl) | ||
CN102227213A (zh) | 适合于衍生化的胰岛素肽的口服施用的药物组合物 | |
JP4123309B2 (ja) | 鼻内投与のための薬学的非無機塩類液剤 | |
KR20120050414A (ko) | 약물의 나노분산액 및 그의 제조 방법 | |
JP7457727B2 (ja) | 徐放性脂質前製剤およびそれを含む脂質溶液の形態の徐放性注射用医薬組成物 | |
WO2011138802A1 (en) | Injection solution | |
JP2024026333A (ja) | 持続放出ペプチド製剤 | |
CA2040237A1 (en) | Long-acting liposome peptide pharmaceutical products and processes for the preparation thereof | |
US20190255068A1 (en) | Prostacyclin analogue formulations | |
PT1787658E (pt) | Formulações de libertação sustentada de análogos de somatostatina inibidores da hormona do crescimento | |
JP6374380B2 (ja) | ソマトスタチン受容体作動薬製剤 | |
KR20030011786A (ko) | 지질 담체 | |
TWI819756B (zh) | 包含塞納布啡的藥物組合物 |